Lack of Gαi2 proteins in adipocytes attenuates diet-induced obesity

Objectives: Typically, obesity results from an inappropriate balance between energy uptake from nutrient consumption and burning of calories, which leads to a pathological increase in fat mass. Obesity is a major cause of insulin resistance and diabetes. Inhibitory G proteins (Gαi) form a subfamily...

Full description

Bibliographic Details
Main Authors: Veronika Leiss, Annika Schönsiegel, Thorsten Gnad, Johannes Kerner, Jyotsna Kaur, Tina Sartorius, Jürgen Machann, Fritz Schick, Lutz Birnbaumer, Hans-Ulrich Häring, Alexander Pfeifer, Bernd Nürnberg
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Molecular Metabolism
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877820301034
id doaj-34f202ff07b54d34853401592e1507ca
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Veronika Leiss
Annika Schönsiegel
Thorsten Gnad
Johannes Kerner
Jyotsna Kaur
Tina Sartorius
Jürgen Machann
Fritz Schick
Lutz Birnbaumer
Hans-Ulrich Häring
Alexander Pfeifer
Bernd Nürnberg
spellingShingle Veronika Leiss
Annika Schönsiegel
Thorsten Gnad
Johannes Kerner
Jyotsna Kaur
Tina Sartorius
Jürgen Machann
Fritz Schick
Lutz Birnbaumer
Hans-Ulrich Häring
Alexander Pfeifer
Bernd Nürnberg
Lack of Gαi2 proteins in adipocytes attenuates diet-induced obesity
Molecular Metabolism
Adipocytes
brown adipose tissue
Gnai2
G proteins
High fat diet
Insulin
author_facet Veronika Leiss
Annika Schönsiegel
Thorsten Gnad
Johannes Kerner
Jyotsna Kaur
Tina Sartorius
Jürgen Machann
Fritz Schick
Lutz Birnbaumer
Hans-Ulrich Häring
Alexander Pfeifer
Bernd Nürnberg
author_sort Veronika Leiss
title Lack of Gαi2 proteins in adipocytes attenuates diet-induced obesity
title_short Lack of Gαi2 proteins in adipocytes attenuates diet-induced obesity
title_full Lack of Gαi2 proteins in adipocytes attenuates diet-induced obesity
title_fullStr Lack of Gαi2 proteins in adipocytes attenuates diet-induced obesity
title_full_unstemmed Lack of Gαi2 proteins in adipocytes attenuates diet-induced obesity
title_sort lack of gαi2 proteins in adipocytes attenuates diet-induced obesity
publisher Elsevier
series Molecular Metabolism
issn 2212-8778
publishDate 2020-10-01
description Objectives: Typically, obesity results from an inappropriate balance between energy uptake from nutrient consumption and burning of calories, which leads to a pathological increase in fat mass. Obesity is a major cause of insulin resistance and diabetes. Inhibitory G proteins (Gαi) form a subfamily that is involved in the regulation of adipose tissue function. Among the three Gαi members, i.e. Gαi1, Gαi2, Gαi3, the Gαi2, protein is predominantly expressed in adipose tissue. However, the functions of the Gαi2 isoform in adipose tissue and its impact on the development of obesity are poorly understood. Methods: By using AdipoqCreERT2 mice, we generated adipocyte-specific Gnai2-deficient mice to study Gαi2 function, specifically in white and brown adipocytes. These mice were fed either a control diet (CD) or a high fat diet (HFD). Mice were examined for obesity development, insulin resistance and glucose intolerance. We examined adipocyte morphology and the development of inflammation in the white adipose tissue. Finally, intracellular cAMP levels as an indicator of Gαi signaling and glycerol release as an indicator of lipolysis rates were measured to verify the impact of Gαi2 on the signaling pathway in brown and white adipocytes. Results: An adipocyte-specific deficiency of Gαi2 significantly reduced diet-induced obesity, leading to decreased fat masses, smaller adipocytes and decreased inflammation in the white adipose tissue relative to littermate controls. Concurrently, oxygen consumption of brown adipocytes and in vivo measured energy expenditure were significantly enhanced. In addition, glucose tolerance and insulin sensitivity of HFD-fed adipocyte-specific Gnai2-deficient mice were improved compared to the respective controls. In the absence of Gαi2, adrenergic stimulation of intracellular adipocyte cAMP levels was increased, which correlated with increased lipolysis and energy expenditure. Conclusion: We conclude that adipocyte Gαi2 is a major regulator of adipocyte lipid content in diet-induced obesity by inhibiting adipocyte lipolysis in a cAMP-dependent manner resulting in increased energy expenditure.
topic Adipocytes
brown adipose tissue
Gnai2
G proteins
High fat diet
Insulin
url http://www.sciencedirect.com/science/article/pii/S2212877820301034
work_keys_str_mv AT veronikaleiss lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT annikaschonsiegel lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT thorstengnad lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT johanneskerner lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT jyotsnakaur lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT tinasartorius lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT jurgenmachann lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT fritzschick lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT lutzbirnbaumer lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT hansulrichharing lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT alexanderpfeifer lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
AT berndnurnberg lackofgai2proteinsinadipocytesattenuatesdietinducedobesity
_version_ 1724573970243518464
spelling doaj-34f202ff07b54d34853401592e1507ca2020-11-25T03:31:03ZengElsevierMolecular Metabolism2212-87782020-10-0140101029Lack of Gαi2 proteins in adipocytes attenuates diet-induced obesityVeronika Leiss0Annika Schönsiegel1Thorsten Gnad2Johannes Kerner3Jyotsna Kaur4Tina Sartorius5Jürgen Machann6Fritz Schick7Lutz Birnbaumer8Hans-Ulrich Häring9Alexander Pfeifer10Bernd Nürnberg11Department of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacoge-nomics and Drug Research, University of Tübingen, 72074, Tübingen, GermanyDepartment of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacoge-nomics and Drug Research, University of Tübingen, 72074, Tübingen, GermanyInstitute of Pharmacology and Toxicology, University of Bonn, 53127, Bonn, GermanyDepartment of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacoge-nomics and Drug Research, University of Tübingen, 72074, Tübingen, GermanyDepartment of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacoge-nomics and Drug Research, University of Tübingen, 72074, Tübingen, GermanyDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University of Tuebingen, Tuebingen, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (IDM), Tuebingen, GermanyGerman Center for Diabetes Research (DZD), Neuherberg, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (IDM), Tuebingen, Germany; Section on Experimental Radiology, Department of Diagnostic and Interventional Radiology, University of Tuebingen, GermanySection on Experimental Radiology, Department of Diagnostic and Interventional Radiology, University of Tuebingen, GermanyNeurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, USA; Institute of Biomedical Research (BIOMED), Catholic University of Argentina, Buenos Aires, ArgentinaDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University of Tuebingen, Tuebingen, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (IDM), Tuebingen, GermanyInstitute of Pharmacology and Toxicology, University of Bonn, 53127, Bonn, GermanyDepartment of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacoge-nomics and Drug Research, University of Tübingen, 72074, Tübingen, Germany; Corresponding author. Department of Pharmacology, Experimental Therapy and Toxicology, University of Tübingen, Wilhelmstr. 56, 72074, Tübingen, Germany. Tel.: +49 7071 29 72267.Objectives: Typically, obesity results from an inappropriate balance between energy uptake from nutrient consumption and burning of calories, which leads to a pathological increase in fat mass. Obesity is a major cause of insulin resistance and diabetes. Inhibitory G proteins (Gαi) form a subfamily that is involved in the regulation of adipose tissue function. Among the three Gαi members, i.e. Gαi1, Gαi2, Gαi3, the Gαi2, protein is predominantly expressed in adipose tissue. However, the functions of the Gαi2 isoform in adipose tissue and its impact on the development of obesity are poorly understood. Methods: By using AdipoqCreERT2 mice, we generated adipocyte-specific Gnai2-deficient mice to study Gαi2 function, specifically in white and brown adipocytes. These mice were fed either a control diet (CD) or a high fat diet (HFD). Mice were examined for obesity development, insulin resistance and glucose intolerance. We examined adipocyte morphology and the development of inflammation in the white adipose tissue. Finally, intracellular cAMP levels as an indicator of Gαi signaling and glycerol release as an indicator of lipolysis rates were measured to verify the impact of Gαi2 on the signaling pathway in brown and white adipocytes. Results: An adipocyte-specific deficiency of Gαi2 significantly reduced diet-induced obesity, leading to decreased fat masses, smaller adipocytes and decreased inflammation in the white adipose tissue relative to littermate controls. Concurrently, oxygen consumption of brown adipocytes and in vivo measured energy expenditure were significantly enhanced. In addition, glucose tolerance and insulin sensitivity of HFD-fed adipocyte-specific Gnai2-deficient mice were improved compared to the respective controls. In the absence of Gαi2, adrenergic stimulation of intracellular adipocyte cAMP levels was increased, which correlated with increased lipolysis and energy expenditure. Conclusion: We conclude that adipocyte Gαi2 is a major regulator of adipocyte lipid content in diet-induced obesity by inhibiting adipocyte lipolysis in a cAMP-dependent manner resulting in increased energy expenditure.http://www.sciencedirect.com/science/article/pii/S2212877820301034Adipocytesbrown adipose tissueGnai2G proteinsHigh fat dietInsulin